Clinical Trials Directory

Trials / Unknown

UnknownNCT02655185

Novel Risk Factors of Atrial Fibrillation in Patients With Chronic Heart Failure

Study to Evaluate Association of Blood Lipid Levels With Atrial Fibrillation Incidence in Patients With Chronic Heart Failure

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Yangzhou No.1 People's Hospital · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether lipid levels are related with incidence of atrial fibrillation in Patients with chronic heart failure.

Detailed description

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice. Chronic Heart failure (CHF) has become a major clinical and public health problem. Both AF and CHF often co-exist and complicate each other's administration.Several risk factors have been demonstrated to be associated with the risk of AF in Patients with CHF. Lopez et al. found that higher levels of low-density lipoprotein cholesterol (LDLc) and total cholesterol were associated with a lower incidence of AF independently of other risk factors from the Atherosclerosis Risk in Communities (ARIC) study. Thus the purpose of this study is to determine whether lipid levels are related with incidence of atrial fibrillation in Patients with chronic heart failure. This study maybe provide a novel opinion on the prevention of AF in patients with CHF.

Conditions

Timeline

Start date
2016-02-01
Primary completion
2018-07-01
Completion
2019-07-01
First posted
2016-01-13
Last updated
2016-01-13

Source: ClinicalTrials.gov record NCT02655185. Inclusion in this directory is not an endorsement.